Oncimmune (AgeTech UK) Medical (Diagnostic Tool)
Biomarker proprietary platform to test for cancer cell signatures, during/post therapy.
Investors
Technology:
AgeTech Companies
Industry:
UK AgeTech 2020
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership